145 related articles for article (PubMed ID: 24083738)
1. Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors?
Demir L; Ekinci N; Erten C; Kucukzeybek Y; Alacacioglu A; Somali I; Can A; Dirican A; Bayoglu V; Akyol M; Cakalagaoglu F; Tarhan MO
Asian Pac J Cancer Prev; 2013; 14(8):4751-8. PubMed ID: 24083738
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.
Wang H; Chen P; Liu XX; Zhao W; Shi L; Gu XW; Zhu CR; Zhu HH; Zong L
World J Surg Oncol; 2014 Apr; 12():89. PubMed ID: 24712384
[TBL] [Abstract][Full Text] [Related]
5. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
Liang YM; Li XH; Li WM; Lu YY
World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
[TBL] [Abstract][Full Text] [Related]
9. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of prognostic factors for patients with gastrointestinal stromal tumors].
Jie ZG; Xie XP; Qin KW; Liu Y; Li ZR; Dai AB; Yao YX
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):210-2. PubMed ID: 16167229
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification in GIST: shape quantification with CT is a predictive factor.
Wei SC; Xu L; Li WH; Li Y; Guo SF; Sun XR; Li WW
Eur Radiol; 2020 Apr; 30(4):1856-1865. PubMed ID: 31900704
[TBL] [Abstract][Full Text] [Related]
12. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
13. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors.
Tai WC; Chuah SK; Lin JW; Chen HH; Huang HY; Kuo CM; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Nov; 20(5):1157-64. PubMed ID: 18949416
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis analysis of 247 cases of gastrointestinal stromal tumor].
Ning L; Zhang DF; Zhou YB; Jiao XL; Cao SG
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):247-50. PubMed ID: 23536345
[TBL] [Abstract][Full Text] [Related]
15. The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses.
Park SJ; Ryu MH; Ryoo BY; Park YS; Sohn BS; Kim HJ; Kim CW; Kim KH; Yu CS; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2014 Dec; 21(13):4211-7. PubMed ID: 24980089
[TBL] [Abstract][Full Text] [Related]
16. Protein S100 as prognostic marker for gastrointestinal stromal tumors: a clinicopathological risk factor analysis.
Perez D; Demartines N; Meier K; Clavien PA; Jungbluth A; Jaeger D
J Invest Surg; 2007; 20(3):181-6. PubMed ID: 17613693
[TBL] [Abstract][Full Text] [Related]
17. [A clinicopathologic and immunohistochemical study on 76 cases of gastrointestinal stromal tumors].
Hou Y; Wang J; Zhu X; Du X; Sun M; Zheng A
Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):20-5. PubMed ID: 11955330
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
[TBL] [Abstract][Full Text] [Related]
19. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs).
Rutkowski P; Nowecki ZI; Debiec-Rychter M; Grzesiakowska U; Michej W; Woźniak A; Siedlecki JA; Limon J; vel Dobosz AJ; Kakol M; Osuch C; Ruka W
J Cancer Res Clin Oncol; 2007 Sep; 133(9):589-97. PubMed ID: 17458563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]